Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms

Neurochemical Research

Volumn 32, Issue 4-5, 2007, Pages 751-756

  Foxton, Richard H ^a   Land, John M ^a,b   Heales, Simon J R ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b National Hospital   (United Kingdom)

Author keywords

Alzheimers; Nitric oxide; Nitrosative stress; Parkinson's; Tetrahydrobiopterin

Indexed keywords

DOPAMINE; GLUTATHIONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; SEROTONIN; TETRAHYDROBIOPTERIN;

ALZHEIMER DISEASE; BRAIN MITOCHONDRION; CATABOLISM; DOPAMINE METABOLISM; ELECTRON TRANSPORT; HUMAN; NERVE DEGENERATION; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 33947572792     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9201-0     Document Type: Review

References (27)

1. Kaufman S (1997) Tetrahydrobiopterin. basic biochemistry and role in human disease. John Hopkins University Press, Baltimore and London
2. Maita N, Hatakeyama K, Okada K, Hakoshima T (2004) Structural basis of biopterin induced inhibition of GTP cyclohydrolase I by GFRP, its feedback regulatory protein. J Biol Chem 279(49):51534-51540
3. Gross SS, Levi R (1992) Tetrahydrobiopterin synthesis. an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267(36):25722-25729
4. Heales SJ, Lam AA, Duncan AJ, Land JM (2004) Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem Res 29(3):513-519
5. Werner ER, Gorren AC, Heller R, Werner-Felmayer G, Mayer B (2003) Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp Biol Med 228(11):1291-1302
6. Brand MP, Heales SJ, Land JM, Clark JB (1995) Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse. J Inherit Metab Dis 18(1):33-39
7. Heales SJ, Canevari L, Brand MP, Clark JB, Land JM, Hyland K (1999) Cerebrospinal fluid nitrite plus nitrate correlates with tetrahydrobiopterin concentration. J Inherit Metab Dis 22(3):221-223
8. Zorzi G, Thony B, Blau N (2002) Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency. J Neurochem 80(2):362-364
9. Heales SJ, Blair JA, Meinschad C, Ziegler I (1988) Inhibition of monocyte luminol-dependent chemiluminescence by tetrahydrobiopterin, and the free radical oxidation of tetrahydrobiopterin, dihydrobiopterin and dihydroneopterin. Cell Biochem Funct 6(3):191-195
10. Gramsbergen JB, Sandberg M, Moller Dall A, Kornblit B, Zimmer J (2002) Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin. Brain Res 935(1-2):47-58
11. Lovenberg W, Levine RA, Robinson DS, Ebert M, Williams AC, Calne DB (1979) Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science 204(4393):624-626
12. Williams AC, Levine RA, Chase TN, Lovenberg W, Calne DB (1980) CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatr 43(8):735-738
13. Barford PA, Blair JA, Eggar C, Hamon C, Morar C, Whitburn SB (1984) Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatr 47(7):736-738
14. Sawada M, Hirata Y, Arai H, Iizuka R, Nagatsu T (1987) Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type. J Neurochem 48(3):760-764
15. Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72(2):355-363
16. Good PF, Hsu A, Werner P, Perl DP, Olanow CW (1998) Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 57(4):338-342
17. Qureshi GA, Baig S, Bednar I, Sodersten P, Forsberg G, Siden A (1995) Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport 6(12):1642-1644
18. Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. the Royal Kings and Queens Parkinson's disease research group. Ann Neurol 32(Suppl):S82-S87 (review)
19. Blair JA, Pearson AJ (1974) Kinetics and mechanisms of the autoxidation of the 2-amin-4-hydroxy-5,6,7,8-tetrahydropterins. J Chem Soc Perkin Trans II 80-88
20. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17(8):2653-2657
21. Vodovotz Y, Lucia MS, Flanders KC, Chesler L, Xie QW, Smith TW, Weidner J, Mumford R, Webber R, Nathan C, Roberts AB, Lippa CF, Sporn MB (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 184(4):1425-1433
22. Delgado-Esteban M, Almeida A, medina JM (2002) Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. J Neurochem 82(5):1148-1159
23. Heales SJ, Bolanos JP (2002) Impairment of brain mitochondrial function by reactive nitrogen species: the role of glutathione in dictating susceptibility. Neurochem Int 40(6):469-474
24. Bolanos JP, Heales SJ, Land JM, Clark JB (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem 64(5):1965-1972
25. Park LC, Zhang H, Sheu KF, Calingasan NY, Kristal BS, Lindsay JG, Gibson GE (1999) Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J Neurochem 72(5):1948-1958
26. Curtius HC, Niederwieser A, Levine R, Muldner H (1984) Therapeutic efficacy of tetrahydrobiopterin in Parkinson's disease. Adv Neurol 40:463-466
27. Cai S, Alp NJ, McDonald D, Smith I, Kay J, Canevari L, Heales S, Channon KM (2002) GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation. Cardiovasc Res 55(4):838-849